Cases & Deals

Medicxi Ventures participates in €18.5 million financing round of Alderaan Biotechnology

Clients Medicxi Ventures (UK) LLP

Jones Day advised Medicxi Ventures in connection with the €18.5 million financing round of Alderaan Biotechnology, a company engaged in the research and development of antibodies targeting certain molecules for the treatment of cancer.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.